Total Antioxidant from Herbal Medicine as a Possible Tool for the Multifunctional Prevention of Muscular Atrophy by Anggi, Viani
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
130,000 155M
TOP 1%154
5,300
1
Chapter
Total Antioxidant from Herbal 
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Abstract
Muscular atrophy is one of disease by the loss of skeletal muscle mass. So, by the loss 
in muscle often causes rapid muscle atrophy and the occurs during injury and illness its 
causes immobilization in spinal muscle mass. Usually, the impact factor of the nervous 
system in musculoskeletal is caused by aging, immobility, malnutrition, medication 
and even the range of injuries disease impact by the nervous system. To meet the needs 
needed by the loss of skeletal, we need high total antioxidant from herbal medicine as 
multifunctional potentially prevention of muscular atrophy condition. Antioxidants 
are agents that can slow down or prevent oxidation process and protect cells system 
from the damage of cell by the loss skeletal in muscle mass. One of herbal medicine is 
Abelmoschus manihot L. Medik From Palu of central Sulawesi as a possible multifunc-
tional prevention of Muscular Atrophy, where the total antioxidant value is 3,45 mg/mL.
Keywords: total antioxidant, herbal medicine, multifunctional prevention,  
muscular atrophy
1. Introduction
Muscular atrophy is one of disease by the loss of skeletal in muscle mass. The 
muscular atrophy recessive autosomal in neuromuscular with characterized of 
alpha motor neuron in the spinal cord [1]. The neuromuscular disorders are one 
factor genetic of infant mortality [2]. The spinal muscular atrophy deletion or 
mutation the Survival motor neuron 1 (SMN 1 gene), reduction of levels functional 
survival motor neuron 1 (SMN 1 gene) and also resulting selective death of spinal 
motor neurons system in a pathway, it’s depends by the age of onset, symptoms 
and maximum function achieved [3]. By the age at the onset it causes at birth: 
Neuromuscular disease, congenital myotonic dystrophy and spinal muscular atro-
phy, other causes are systematic septicemia-induced disease, lung damage, intracra-
nial pathologies, infection of the central nervous system, disorders of the peripheral 
nerves, disease of the neuromuscular junction, Prader-Willi syndrome and drug 
intoxication during pregnancy or delivery system and after 6 months of age were 
the neuromuscular disease: spinal muscular atrophy types II and III, polyneuropa-
thies, childhood myasthenia gravis, muscular dystrophies and metabolic myopathy 
and besides that in other causes were congenital heart disease, malnutrition, rickets, 
metabolic diseases, nephropathies and lung diseases [4, 5]. The clinical prognosis of 
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spinal muscular atrophy is variable and depends on types of spinal muscular atro-
phy continuous spectrum with the age of death by infancy to normal life expectancy 
condition system on cell pathway system [6]. The Muscular atrophy its described 
with characterized generalized muscle and atrophy in the proximal limb muscle and 
phenotype by four grades of severity, where the spinal Muscular Atrophy I, spinal 
Muscular Atrophy II, spinal Muscular Atrophy III and spinal Muscular Atrophy IV, 
it’s all depended by onset and motor spinal function [7, 8]. The muscular atrophy 
disease by the control mutation in the homozygous of survival motor neuron α 
(SMN 1) gene. The skeletal of muscular atrophy it’s adverse consequences and the 
mechanism such as wasting or decrease of injury time. Lack of use in the spinal 
muscular atrophy and event disease category of spinal muscular atrophy. The spinal 
muscular atrophy it’s usually considered by chronic diseases such as poliomyelitis, 
Diabetes mellitus, cancer, renal failure or pulmonary obstruction [1].
To activation of spinal muscular atrophy, we need the process to activation of the 
distinct pathway (ATP) in proteolysis pathway. The condition of spinal muscular 
atrophy it’s depends on the level of muscle protein nutrition system. To reduce the 
fiber muscle we need synthesis protein to innervate proximal hindlimb muscles and 
medical motor neurons axial muscles [9]. Mitochondrial is important in skeletal 
muscle to activation of function and subpopulation involved in cellular functions. 
Mitochondria play in role key on muscle fibers to the regulation of myonuclear 
apoptosis and serving uptake the calcium [10]. Mitochondria also continuously 
produce superoxide radicals and dismutated into hydrogen peroxide (H2O2), where 
H2O2 is a relatively and diffuse freely with cytosol, it’s very important as signaling to 
the molecule on cell, to affecting multiple control of the cell cycle, uptake to cellular 
stress response, activation energy metabolism and also to the expression of numer-
ous redox-sensitive genes in spinal muscular atrophy disease [9].
2. Prevalence, incidence and carrier frequency of muscular atrophy
According to the worldwide about a study into the prevalence and incidence 
of spinal muscular atrophy, where approximately 1–2 per 100.000 people and 
incidence around 1 in 10.000 live births have been estimated with the spinal 
muscular atrophy type I accounting for around 60% of all cases and estimation of 
the incidence of all types of spinal muscular atrophy of around 10 in 100.000 (1 in 
10.000) live birth is cited [11]. Every incidence is a factor from a number of new 
cases of the disease in a particular time period. The evaluation of the incidence of 
all type SMA combined it’s around 8 per 100.000 live births. The incidence of spinal 
muscular atrophy type I is around 4–6 in 100.000 and for the type II and III it’s a 
high incidence combined 10,6 per 100.000 and for the gender, it’s a nearly even split 
male and female [12]. The indicated difference of spinal muscular atrophy types is 
the between ethnicities and differences in health system clinically diagnosed. The 
prevalence in Indonesia of neuromuscular in RSCM hospital from January –  
December 2017 is 2,6% of all patients who come to the neurology outpatient ward. 
The five most who have neuromuscular disorders are neuropathy peripheral, 
Duchenne muscular dystrophy, spinal muscular atrophy, Guillain barre syndrome 
and chronic inflammatory demyelinating polyneuropathy [13].
3. Genetics of spinal muscular atrophy
Spinal muscular atrophy is a defect in survival motor neuron 1 (SMN 1) and it’s 
gene localized to 5q11.2-q13.3). SMN gene (SMN 1 and SMN 2) on chromosome 
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5q13 and the homozygous deletion of the SMN 1 gene result in Spinal muscular 
atrophy. Besides that, the SMN 2 gene it produces mostly a shortened, unstable the 
survival motor neuron mRNA and also to alternative splicing, a small amount of 
full – length on functional SMN mRNA. The SMN 2 gene is a good prognostic of 
the spinal muscular atrophy in clinical severity. The clinical severity management 
of spinal muscular atrophy disease is supportive to increase the survival motor 
neuron expression levels in motor neurons cells system. So, the management of 
spinal muscular atrophy depends on increase SMN expression levels in motor 
neurons [3].
The survival motor neuron 1 gene it should be sequenced mutations if both 
full SMN 1 present of diagnosis on spinal muscular atrophy is highly, but the SMN 
1 gene should be sequenced if the striking typical phenotype, where if sequenc-
ing indicates and intact SMN 1 gene of phenotype suggestive of spinal muscular 
atrophy neurogenic. The survival motor neuron 2 gene should be routinely assessed 
and it’s important to factor system influencing the severity of the spinal muscular 
atrophy phenotype [1].
4. Molecular oxidative stress factor of muscular atrophy
Factor oxidative stress of muscle atrophy it’s important to maintenance and 
quality to the rehabilitation of disease. The skeletal of muscle atrophy need continu-
ously produce oxidants like as a reactive oxygen species (ROS) and reactive nitrogen 
species (RNS) to an imbalance of skeletal muscle mechanism process. The soluble 
atrophy it’s produced different oxidative stress state species such as O2
−, H2O2 and 
OH−. Where, it also needs antioxidant species state such as catalase, glutathione 
peroxidase (GPx) and superoxide dismutase (SOD) and the last to imbalance 
denominated of oxidative stress, it’s can produce oxidative damage in lipids, 
Deoxyribonucleic acid (DNA) and protein to impairing functional protein factor of 
cellular system [14].
Generation of ROS could uptake of oxygen, activation of NADPH oxidase and to 
production of the superoxide anion radical, see the reaction:
 
oxidase
2 2
2O NADPH 2O NADP H
- + +
+
® + +  (1)
Where O2
− is converted to H2O2 (Eq. (2) by SOD
 
2 2 2 2
2O 2H H O O
SOD
+
+
® +  (2)
The skeletal of muscle atrophy could inactivity increase of mitochondrial reac-
tive oxygen species (ROS) production on the ways. The mitochondrial could uptake 
of calcium and increase mitochondrial levels state of fatty acid hydroperoxides and 
the last depressed protein could transport into the mitochondria system. So, if the 
mechanism responsible, it’s could increase mitochondrial fission [9].
The observation of muscle mass-specific overexpression of Peroxisome 
proliferator-activated receptor-y-coactivator-1α (PGC-1α) and the master regula-
tor of mitochondria biogenesis could prevent activation of catabolic system and 
disuse of muscle atrophy system. The Peroxisome proliferator-activated receptor-
y-coactivator-1α (PGC-1α) is mediated pathway and focuses on the role PGC-1α 
in the skeletal spinal muscular atrophy system by immobilization system. The 
Peroxisome proliferator-activated receptor-y-coactivator-1α (PGC-1α) is the master 
transcription stimulates of mitochondrial biogenesis pathway system with up the 
regulating system of the nuclear respiratory factors (NRF-1,2) and mitochondrial 
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transcription factor A (Tfam) system, so it leads to increased mitochondrial DNA 
replication system and gene transcription system [15]. The Peroxisome proliferator-
activated receptor-y-coactivator-1α (PGC-1α) to appears key to the role-play a 
protective against of muscular atrophy linked skeletal muscle deterioration. The 
Peroxisome proliferator-activated receptor-y-coactivator-1α (PGC-1α) interacts 
with the nuclear receptors and activate transcription factors to activated their target 
gene. The activity to responsive multiple stimuli including calcium ion, Reactive 
oxygen species (ROS) and ATP demand pathway system on the cell system in the 
spinal muscular atrophy. The metabolic stress mediated by PGC-1α downregulation 
plays a major role in muscle atrophy and to adaptation the soleus to mice hindlimb 
unloading (HU) in the defuse, we need antioxidant treatment (Trolox). Which, the 
HU caused of reduction in the cross-sectional area, redox status alteration (NRF2, 
Superoxide dismutase1 and catalase up-regulation) and the autophagy (Beclin1 
and P62 mRNA up-regulation) [16]. The attractive of PGC-1α states in muscle 
mass could restore and promote the muscle metabolic system when normal physi-
cal activity impossible. The observation of the muscle fiber – specific event until 
overexpression of the attractive of PGC-1α states, where a master regulator of the 
mitochondrial biogenesis, to prevent activation produce of the catabolic system and 
also disuse muscle atrophy.
5. Antioxidant mechanism and function
The natural antioxidant is one important to underlying to spinal muscular 
atrophy system. The natural antioxidant could effect to exercise the health- 
promoting increase muscle defenses [17]. The natural antioxidant which role-plays 
to activation integrity on the cell and to prevent the free radical configuration 
tissue damage of muscle atrophy to normal healthy condition system of muscle 
atrophy pathway [18].
The natural antioxidant increasing antioxidative defenses and develop a synthesis 
of endogenous enzymes or increased antioxidant utilization, practice to maintain 
optimal body function to especially of spinal muscular atrophy in the redox condi-
tion on cell [19]. The function from natural antioxidant: it reduces the free radical 
of spinal muscular atrophy, stimulates the growth of normal cells, to protects the 
cell against the premature and abnormal aging condition of spinal muscular atro-
phy, helps fight the age-related molecular degeneration of spinal muscular atrophy 
and the last to supports the body immune system [17]. The natural antioxidant is 
powerful electron donors and also to the reaction of free radicals to target molecules 
breaking damaged on skeletal muscular. The lipid phase of chain-breaking antioxi-
dant can scavenge the radicals in membranes and lipoprotein particles to preventing 
lipid peroxidation of skeletal muscular atrophy. The lipid phase such as tocopherols, 
ubiquinol, carotenoids and flavonoids and the aqueous phase such as ascorbate, 
urate, glutathione and other thiols [20, 21].
6. Flavonoids are group of antioxidants
Flavonoids are a group from based on natural substances by a variable phenolic 
structure, where are found from fruits, vegetables, grains, bark, roots, stems, flowers, 
tea and wine. Flavonoids are potential to anti-oxidative, anti-inflammatory and anti-
mutagenic on spinal muscular atrophy disease [22]. As an anti-inflammatory, we need 
of agent system, where the COX is an endogenous enzyme with catalyzes function, 
which the conversion of arachidonic acid into prostaglandins and thromboxanes, 
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where the enzyme exists in two isoforms: COX - 1 is a constitutive enzyme and is 
responsible for the supply of prostaglandin and Cox – 2 is an inducible enzyme and is 
expressed an inflammatory stimulus and the stimulus prostaglandin to induction of 
inflammatory and pain. By using, the flavonoids can activate the molecular docking 
and knowledge bioinformatics in preventing chronic disease like as spinal muscular 
atrophy and to application and manufacturing in pharmaceutical medicinal industry 
[23]. Flavonoids subdivided of subgroup depending on the carbon of the C ring on 
which the B ring, which the degree of unsaturation and oxidation of the C ring. The 
firs isoflavone, which in the B ring is linked position 3 of the C ring. Second, the 
neoflavonoids, which the B ring is linked in position 4. Besides that, the subdivided 
into several subgroups on the basis which the B ring is linked position 2 on the basis 
of the structural features of the C ring. Flavonol (e.g. Quercetin, myricetin), flavone 
(eg. apigenin, luteolin), flavonolols (eg. taxifolin), flavan-3-ols (eg catechin, epigal-
locatechin), flavovone [24] (eg. hesperitin, naringenin), anthocyanidin (eg. cynidin, 
delphidin), isoflavone (eg. genistein, daidzein).
7. Abelmoschus manihot L. Medik is one of herbal medicine
Abelmoschus manihot L. Medik is have highest total antioxidant (Table 1). The 
leaf plant is a tropical plant from china, which is trapped by the name Huangkui. 
Ethanobotanical uses and phytochemical analysis of Abelmoschus manihot L. Medik, 
where the preliminary study shows the presence of alkaloid, carbohydrates, tan-
nins, steroid and glycosides [25].
8.  Ethanomedicinal, phytochemical and pharmacological  
of Abelmoschus manihot
Ethanomedicinal, phytochemical and pharmacological profile of genus 
Abelmoschus manihot L. Medik where the genus Abelmoschus manihot L. Medik 
has been reported to used for several ethnomedicinal practices and also dem-
onstrated diverse pharmacological activities and posses several phytochemical 
and nutritional properties as well as having and no adverse effect on living cells, 
their pods, seeds and leaves are reported to be used in pharmaceutical industries 
Compound Name
1 Hyperoxide/ 
Hyperin
Dihydroxyphenil)-3-{3R,4S,5R,6R)-3,4,5-trihydroxy-6(hydroxymethyl)
oxan-2-yl}oxy-4H-chromene-4,5,7-triol
2 Isoquercetin 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3{(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-
6-(hydroxymethyl)oxan-2-yl} oxychromen-4-one
3 Myricetin 3,5,7-Trihydroxy-2-(3,4,5)-trihydroxyphenyl-4-chromenone
4 Hibifolin quercetin 3-beta-robinobioside; 3{(6–0-(6-Deoxy-alpha-L-
mannopryranosyl)-beta-D-galactopyranosyl}oxy)-2-(3,4-dihydroxy 
phenyl)5,7-dihydroxy-4H-1-benzopyran-4-one
5 Quercetin 3-O-robinoside: Quercetin 3 –beta-robinobioside; 3-{(6-O-(Deoxy-
alpha-L-mannopyranosyl)-beta-D-galactopyranosy}
oxy)-2-(3,4-dihydroxyphenyl-4H-1-benzopyran-4-one
6 Coumarin 
scopoletin
7-hydroxy-6-methoxychromen-2-one
Table 1. 
Some compounds isolated from the genus Abelmoschus manihot L. Medik [26].
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and traditional remedies all over the world [26]. The protective effect on the 
total flavonoid of Abelmoschus manihot L. Medik on transient cereberal ischemia-
preperfusion injury is due to activation of the Nrf2-are pathway, where the highest 
total flavonoids 788,56 mg/g) of all the different part, the protective effects of 
an extract of the total flavonoids of Abelmoschus manihot L. Medik on transient 
cereberal ischemia–reperfusion injury (TCI-RI) were investigated, these data 
suggest that to protects against TCI-RI by scavengin free radical and activating 
NRF2-ARF pathway (Nuclear factor E2-related factor 2 contributes to neuropto-
tective immune system, antioxidation, antifatigue and anti-inflamatory properties 
[27]. The bioactive compounds from Abelmoschus manihot L. Medik alleviate the 
progression of multiple myeloma in mouse model and improve bone marrow envi-
ronment, where the Abelmoschus manihot L. Medik derived as a Huangkui capsules 
(HKC) represent a traditional Chinese medicine that has been widely applied to 
the clinical therapy of kidney and inflamatory disease by methods expressions 
of certain proteins were detected via western blotting, transcriptomic RNA-
sequencing as well as RT-qPCR, where the result revealed that MM-Prone animals 
appeared to be protected following HKC treatment as evidence by a prolonged 
survival rate, which four of the nine flavonoid compounds (Hyperin/hyperoxide, 
HK-2; cannabiscitrin, HK-3, 3-O-kaempferol-3-O-acetyl-6-O-(p-coumaroyl)-
β-D-glucopyranosid, HK-11, 8-(2-pyrolidione-5-yl)-3-O-β-D-glucopyranosid, 
HK-E3) suppressed osteoclastogenesis in murine raw 264.7 cells.HK-11 directly 
inhibited MM cells (ARP1 and h929) proliferation and induced G0/G1 cell cycle 
arrest, which may have involved suppressing β-catenin protein, increasing expres-
sion of IL-6 and TNF-α, as well as activating mature TGF-β1 and some other 
metabolic pathways [28]. Abelmoschus manihot L. Medik have supplementation as 
a Nephropathy system by methods a combined treatment of a high – fat diet and 
streptozotocin after unilateral nephrectomy and supplementation of Abelmoschus 
manihot L. Medik were tested, the results is preventive effects of the extracts on 
Nephropathy pathology system and changes on autophagy mitocondrial proteins 
were investigated to showed significant increase in fasting blood glucose, plasma 
creatinine, blood urea nitrogen and urinary albumin levels [29]. Abelmoschus 
manihot L. Medik as a Huangkui in Chinese, where as a traditional Chinese 
medicine, the Huangkui has been used for medication of the patients as a reduce 
inflammation anti-oxidative stress, improving immune response system, protect-
ing renal tubular epithelial cells, ameliorating podocyte apoptosis, glomeruloscle-
rosis and mesangial proliferation, as well as inhibiting on cellular and molecular 
mechanism [30]. So, with the natural antioxidant as a reduces the free radical of 
spinal muscular atrophy and stimulates the growth of normal cells. In Palu city 
of central Sulawesi Indonesia, where the plant is known as one of the raw based 
material of vegetables and is usually mixed with pulp.
9. Total antioxidant of Abelmoschus manihot (L.) Medik
This plant is believed to have medicinal based properties, because are many 
compound vitamins, like as: A, B1, B2, B3, C and E, compound the calcium, 
potassium, copper, zinc and many collagen. This plant also contains secondary 
metabolites like as: Flavonoids, Saponin and phonolite, where it has used as an 
antioxidant. The evaluate total antioxidant arrest activity using the DPPH (IC50) 
of Abelmoschus manihot (L.) Medik extracts from Palu of Central Sulawesi, the 
method is displayed in Table 2 and Figure 1, evaluate the potential activity of the 
test substances for the cytotoxicity against selected 4 T1 cell lines and Vero cell 
of Abelmoschus manihot (L.) Medik extracts from Palu of Central Sulawesi. The 
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cytotoxicity potential of various concentration of ethanol, ethyl acetate, N-Heksan 
extracts with CTC50 values of leaf Abelmoschus manihot (L.) Medik is displayed in 
Tables 3 and 4 and Figures 2 and 3. Leaf Abelmoschus manihot (L.) Medik from 
Palu of Central Sulawesi extract plant shows the total antioxidant is 3,45 μg/ml 
from reports arrest of DPPH (IC50) is displayed in Table 2 and Figure 1. According 
to the criteria to the level of antioxidant power with DPPH (IC50) method, where 
the extract of natural ingredients with IC50 < 50 μg/ml is potential. The in-vitro 
cytotoxicity effects of leaf Abelmoschus manihot (L.) Medik from Palu of Central 
Sulawesi, where carried with various concentrations to the breast cancer cell lines 
4 T1 and have Potentially Toxicity, where the leaf of Abelmoschus manihot (L.) 
Medik of the medicinal plant was collected from Palu of central Sulawesi and 
extracted with ethanol solvent with use of Six different concentrations (31.25 μg/ml, 
62.5 μg/ml, 125 μg/ml, 250 μg/ml, 500 μg/ml and 1000 μg/ml) of leaf extracts were 
used to investigate study the in-vitro cytotoxicity concentration potential of the 
medicinal plant. The cytotoxicity potential of various extracts is N-Heksan extract 
of Abelmoschus manihot (L.) Medik with CTC50 values of Abelmoschus manihot (L.) 
Medik is displayed in Table 3 and Figure 2. The results that the cytotoxicity rate 
has increased when the concentrations of leaf Abelmoschus manihot (L.) Medik 
extracts increases. MTT assay measured the viability cell based on the reduction 
of yellow tetrazolium MTT to a purple formazan dye by mitochondrial succinate 
dehydrogenase enzyme. Where the amount of formazan produced reflected the 
number of metabolically active 4 T1 cells Line (Breast Cancer). The test substances 
Leaf Extract (ethanol), Leaf Extract (ethyl acetate) and Leaf Extract (N-Heksan) 
were exhibited a CTC50 value of 261.84 ± 0.13 μg/ml, 288.29 ± 0.10 μg/ml and 
185.06 ± 0.12 μg/ml. According to the criteria value of the cytotoxicity level of 
extracts, if an excerpt of natural ingredients with CTC50 < 100 μg/ml is very active, 
the CTC50 value of 100–200 μg/ml is quite active and > 200 μg/ml is weak [31]. The 
Name of Test
Substance
Antioxidant Activity DPPH IC50 (mg/mL)
Leaf Abelmoschus manihot (L.) Medik extract 3,45
Table 2. 
The antioxidant activity DPPH (IC50) of leaf Abelmoschus manihot (L.) Medik [32].
Figure 1. 
Graph of total antioxidant of Abelmoschus Manihot.
Background and Management of Muscular Atrophy
8
results of N-Heksan leaf extract Abelmoschus manihot (L.) Medik has quite poten-
tially to the cytotoxicity. The N-Heksan leaf extract Abelmoschus manihot (L.) Medik 
shows the better percentage of growth inhibition CTC50 is 185.06 ± 0.12 μg/ml 4 T1 
cell lines. To the Doxorubicin of cytotoxicity CTC50 with value 4 T1 cells line is 
13,57 ± 0.10 μg/ml, where this value shows is toxic of Doxorubicin to 4 T1 cells Line 
(Breast Cancer). The cytotoxicity with various concentrations of all leaf extracts 
does not have potentially the cytotoxicity on Vero (normal) cell, where the cytotoxic-
ity with value CTC50 ≥ 200 μg/ml. The test substances Leaf Extract (ethanol), Leaf 
Extract (ethyl acetate) and Leaf Extract (N-Heksan), were exhibited a CTC50 value of 
588.39 ± 0.13 μg/ml, 451.41 ± 0.11 μg/ml and 559.12 ± 0.13 μg/ml. According to the cri-
teria value of the cytotoxicity level of extracts, if an extract of natural ingredients with 
CTC50 < 100 μg/ml is very active, the CTC50 value of 100–200 μg/ml is quite active 
and > 200 μg/ml is weak, where is displayed in Table 4 and Figure 3. Results that the 
cytotoxicity rate has increased when the concentrations of leaf Abelmoschus manihot 
(L.) Medik extracts increases. To the Doxorubicin cytotoxic CTC50 value to Vero 
(normal) cells is 60.85 ± 0.13 μg/ml, this shows is toxic from according to the criteria 
NO Name of Test
Substance
Test Conc.  
(μg/ml)
% Cytotoxicity CTC50 (μg/ml)
1 Leaf extract (Ethanol) 1000 83.31 ± 0.003 261.84 ± 0.13
500 73.44 ± 0.014
250 54.25 ± 0.025
125 19.93 ± 0.020
62.5 18.64 ± 0.066
31.25 2.56 ± 0.049
2 Leaf extract (Ethyl Acetate) 1000 66.28 ± 0.016 288.29 ± 0.10
500 57.02 ± 0.007
250 54.45 ± 0.019
125 40.81 ± 0.025
62.5 28.17 ± 0.011
31.25 12.29 ± 0.020
3 Leaf extract (N-Heksan) 1000 94.45 ± 0.006 185.06 ± 0.12
500 67.77 ± 0.014
250 52.36 ± 0.038
125 37.50 ± 0.005
62.5 25.33 ± 0.015
31.25 16.55 ± 0.017
4 Doxorubicin 100 68.24 ± 0.007 13.57 ± 0.10
50 62.50 ± 0.007
25 53.51 ± 0.017
12.5 47.09 ± 0.109
6.25 42.29 ± 0.009
3.12 40.00 ± 0.002
CTC50- Cytotoxicity concentration.
Table 3. 
Cytotoxic properties of test substances of leaf Abelmoschus Manihot (L.) Medik on 4 T1 cell line [32].
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No Name of Test
Substance
Test Conc. (μg/ml) % Cytotoxicity CTC50 (μg/ml)
1 Leaf extract (Ethanol) 1000 57.98 ± 0.051 588.39 ± 0.13
500 56.43 ± 0.062
250 23.33 ± 0.027
125 19.74 ± 0.006
62.5 9.29 ± 0.006
31.25 0.00 ± 0.038
2 Leaf extract (Etil Acetat) 1000 65.34 ± 0.005 451.41 ± 0.11
500 54.98 ± 0.003
250 38.52 ± 0.006
125 25.75 ± 0.002
62.5 9.39 ± 0.002
31.25 0.77 ± 0.006
3 Leaf extract (N-Heksan) 1000 68.44 ± 0.005 559.12 ± 0.13
500 37.07 ± 0.101
250 31.55 ± 0.004
125 26.42 ± 0.010
62.5 12.58 ± 0.056
31.25 0.00 ± 0.030
4 Doxorubicin 100 99.71 ± 0.011 60.85 ± 0.13
50 94.77 ± 0.005
25 84.60 ± 0.065
12.5 58.95 ± 0.057
6.25 52.95 ± 0.064
3.12 37.27 ± 0.008
CTC50- Cytotoxicity concentration.
Table 4. 
Cytotoxic properties of test substances against on Vero cells [32].
Figure 2. 
Graph of cytotoxic effect on 4 T1 cells line of Abelmoschus Manihot (L.) Medik [32].
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value of cytotoxicity level [32]. The medicinal plant of leaf Abelmoschus manihot (L.) 
Medik from Palu of Central Sulawesi extract, where can be used to prepare the natural 
antioxidant and to prepare the pharmaceutical-based natural drug with proper 
standardization methods. Medicinal plants are a source of important therapeutic 
for alleviating human ailments and the medicinal plants have bioactive compounds, 
which are used for curing various human disease and also play an essential role key in 
chronic disease to especially on spinal muscular atrophy cell system pathway [33]. The 
natural antioxidant as a reduces the free radical of spinal muscular atrophy, stimulates 
the growth of normal cells, to protects the cell against the premature and abnormal 
aging condition of spinal muscular atrophy, helps fight the age-related molecular 
degeneration of spinal muscular atrophy and the last to supports the body immune 
system [34, 35].
10. Summary
The muscular atrophy recessive autosomal in neuromuscular with characterized 
of alpha motor neuron in the spinal cord, the neuromuscular disorders is one factor 
genetic of infant mortality and the spinal muscular atrophy deletion or mutation 
the Survival motor neuron. Spinal muscular atrophy is a defect in survival motor 
neuron 1 (SMN 1) and it’s gene localized to 5q11.2-q13.3). SMN gene (SMN 1 and 
SMN 2) on chromosome 5q13 and the homozygous deletion of the SMN 1 gene 
result in Spinal muscular atrophy. The spinal muscular atrophy disease need of 
natural antioxidant as a reduces the free radical of the fiber muscle cell, stimulates 
the growth of normal cells, to protects the cell against the premature and abnor-
mal aging condition of spinal muscle fiber, helps fight the age-related molecular 
degeneration of spinal muscular cell and the last to supports the body immune 
system. The medicinal plant of leaf Abelmoschus Manihot (L.) Medik from Palu of 
Central Sulawesi extract, where can be used to prepare the natural antioxidant and 
to prepare the pharmaceutical-based natural drug with proper standardization 
methods. Medicinal plants are a source of important therapeutic for alleviating 
Figure 3. 
Graph of the cytotoxic effect of Abelmoschus Manihot (L.) Medik on Vero cell [32].
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human ailments and medicinal plants have bioactive compounds, which are used 
for curing various human disease and also play an essential role key in chronic 
disease to especially on spinal muscular atrophy cell system pathway.
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